Faculty

Institution

Unit

Venue

Chandra Belani

Professor

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Radiation Oncology

Chandra Belani is currently serving as a Radiation Oncology Professor at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Chandra Belani

Pennsylvania State University

Professor

You can click a keyword to filter the displayed items

oncology lung cancer thoracic oncology radiation oncology cancer research cancer treatment pharmacology medicine cancer care respiratory medicine medicinal research cancer management clinical research pharmacotherapy anti-cancer agents cancer immunotherapy cancer biology clinical trials health sciences tumor biology surgical oncology tumor targeting therapeutic targets clinical radiation oncology cellular therapy medical mycology radiation therapy clinical mycology thoracic surgery non-small-cell lung cancer enzyme inhibition cancer genomics cancer genetics drug trials drug targeting oncogenes clinical evidence molecular cancer gastrointestinal oncology genitourinary cancers phase ii study hematological malignancies pharmacokinetics clinical investigation cancer growth small-cell lung cancer clinical pharmacology tumor suppressors advanced solid malignancies palliative medicine photomedicine clinical therapeutics combined modality treatment treatment options cancer risk therapeutic efficacy liver cancer advanced solid tumors maintenance therapy experimental medicine meta-analysis treatment development oncologic imaging phase ii trial pharmacokinetic study advanced nsclc esophageal cancer cancer prevention advanced malignancies elderly patients thoracic radiation hepatocellular carcinoma phase iii study weekly paclitaxel histone deacetylase inhibitor pharmacodynamic study next-generation therapies cancer institute biomarker target systems biology molecular diagnostics metabolomics precision medicine pathology clinical translation clinical proteomics

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characterization of Effective, Simple, and Low‐Cost Precipitation Methods for Depleting Abundant Plasma Proteins to Enhance the Depth and Breadth of Plasma Proteomics. PROTEOMICS (2024)

Shawn J. RiceChandra P. Belani

low-cost precipitation methodsproteomicsenvironmental scienceplasma proteomics

A Phase 1 Study of Veliparib (Abt-888) Plus Weekly Carboplatin and Paclitaxel in Advanced Solid Malignancies, With an Expansion Cohort in Triple Negative Breast Cancer (Tnbc) (Etctn 8620). Breast Cancer Research and Treatment (2023)

Monica K. MalhotraShalu PahujaBrian F. KieselLeonard J. ApplemanFei DingYan LinHussein A. TawbiRonald G. StollerJames J. LeeChandra P. BelaniAlice P. ChenVincent L. GirandaStacie Peacock ShepherdLeisha A. EmensS. Percy IvyEdward ChuJan H. BeumerShannon Puhalla

tumor targetingmedicineoutcomes researchpharmacologycancer careadvanced solid malignanciesexpansion cohortcancer managementradiation oncologycancer researchanti-cancer agentsweekly carboplatinoncologybreast cancerclinical researchmedicinal researchcancer treatmentcancer biology

Design of Experiments Approach for Systematic Optimization of a Single‐Shot Diapasef Plasma Proteomics Workflow Applicable for High‐Throughput. PROTEOMICS - CLINICAL APPLICATIONS (2023)

Shawn J. RiceChandra P. Belani

proteomicssystematic optimizationbiomedical engineeringclinical proteomics

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. Journal of Thoracic Oncology (2023)

Sanja DacicWilliam TravisMary RedmanAnjali SaqiWendy A. CooperAlain BorczukJin-Haeng ChungCarolyn GlassJavier Martin LopezAnja C. RodenLynette ShollAnnikka WeissferdtJuan PosadasAngela WalkerHu ZhuManuja T. WijeratneCasey ConnollyMurry WynesNeus Bota-RabassedasBeatriz Sanchez-EspiridionJ.Jack LeeSabina BerezowskaTeh-Ying ChouKeith KerrAndrew NicholsonClaudia PoleriKurt A. SchalperMing-Sound TsaoDavid P. CarboneNeal ReadyTina CasconeJohn HeymachBoris SepesiCatherine ShuNaiyer RizviJosuha SonettNasser AltorkiMariano ProvencioPaul A. BunnMark G. KrisChandra P. BelaniKaren KellyIgnacio Wistuba

survival analysiscancer riskpathologyreproducible researchlung cancer studypathologic responsemedicinecancer managementcancer genomicscancer researchsurgical oncologycancer treatmentlung cancerthoracic oncologyradiation oncologyresected lung cancersoncologyclinical researchrespiratory medicinemedicinal researchneoadjuvant therapyexperimental medicine

Natural History and Real-World Treatment Outcomes for Patients With Nsclc Having Egfr Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology Cancerlinq Study. JTO Clinical and Research Reports (2023)

Madhusmita BeheraRenjian JiangZhonglu HuangBecky BunnMurry W WynesJeffrey SwitchenkoGiorgio V ScagliottiChandra P BelaniSuresh S Ramalingam

cancer geneticsepidemiologyclinical case reportfield trialcancer carecancer researchsurgical oncologynatural historylung cancerinsertion mutationradiologythoracic oncologyradiation oncologyclinical case presentationcancer discoveryreal-world treatment outcomesclinical trialsoncologyclinical researchclinical investigationtreatment options

A Phase 1 and Pharmacodynamic Study of Chronically-Dosed, Single-Agent Veliparib (Abt-888) in Patients With Brca1- or Brca2-Mutated Cancer or Platinum-Refractory Ovarian or Triple-Negative Breast Cancer. Cancer Chemotherapy and Pharmacology (2022)

Julia ManzoShannon PuhallaShalu PahujaFei DingYan LinLeonard ApplemanHussein TawbiRonald StollerJames J. LeeBrenda DiergaardeBrian F. KieselJing YuAntoinette R. TanChandra P. BelaniHelen ChewAgustin A. GarciaRobert J. MorganAndrea E. Wahner HendricksonDaniel W. VisscherRachel M. HurleyScott H. KaufmannElizabeth M. SwisherSteffi OesterreichTiffany KatzJiuping JiYiping ZhangRalph E. ParchmentAlice ChenWenrui DuanVincent GirandaStacie P. ShepherdS. Percy IvyEdward ChuJan H. Beumer

pharmacodynamic studymedicinetriple-negative breast cancerpharmacologycancer carecancer researchsingle-agent veliparibpharmacotherapyanti-cancer agentsbreast canceroncologycancer treatment

A Phase 1, Open-Label, Dose-Escalation Study of L-Dos47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous Nsclc. JTO Clinical and Research Reports (2022)

Sarina Piha-PaulGeorge SimonChandra P BelaniHeman ChaoKim GasparBrenda LeeAfshin Dowlati

hematological malignanciesdose-escalation studyoutcomes researchpharmacologystage iv recurrentcombined modality treatmentradiation oncologymetastatic nonsquamous nsclcclinical case reportpharmacotherapyclinical trialsoncologyclinical researchmedicinal researchclinical investigationcancer treatmentexperimental medicinedrug trials

A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-Small Cell Lung Cancer and Their Role in the Development of Ecog-Acrin Ea5181. Clinical Lung Cancer (2022)

John Michael VarlottoZhuoxin SunBonnie KyJenica UpshawThomas J FitzgeraldMax DiehnChristine LovlyChandra BelaniKurt OettelGregory MastersMatthew HarkenriderHelen RossSuresh RamalingamNathan A Pennell

medicineradiologycancer carethoracic oncologyradiation oncologycancer researchradiation therapy planningradiation biologyclinical radiation oncologyoncologyrespiratory medicineradiation therapycancer treatmentradiationlung cancerradiation planningimmunotherapy

Molecular Testing and Patterns of Treatment in Patients With Nsclc: An Iaslc Analysis of Asco Cancerlinq Discovery Data.. Journal of Clinical Oncology (2022)

Madhusmita BeheraGregory JosephManali RupjiZhonglu HuangBecky BunnMurry WynesJeffrey M. SwitchenkoGiorgio V. ScagliottiKristin Ann HigginsMing Sound TsaoChandra Prakash BelaniLecia V. SequistSuresh S. Ramalingam

hematological malignanciescancer geneticsclinical evidenceiaslc analysiscancer careclinical chemistrymolecular cancercancer genomicsmolecular diagnosticsoncologic imagingleukemiacancer researchcancer immunotherapypharmacologyradiation oncologyclinical trialsmolecular biologyclinical researchoncologymolecular testing

Optimizing Data‐Independent Acquisition (Dia) Spectral Library Workflows for Plasma Proteomics Studies. PROTEOMICS (2022)

Shawn J. RiceChandra P. Belani

proteomicsdata-independent acquisitiondata scienceplasma proteomics studiesspectral library workflows

1
2
3
4
5
31
10 / page

Chandra Belani

Professor

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Radiation Oncology

Chandra Belani is currently serving as a Radiation Oncology Professor at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Chandra Belani

Pennsylvania State University

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characterization of Effective, Simple, and Low‐Cost Precipitation Methods for Depleting Abundant Plasma Proteins to Enhance the Depth and Breadth of Plasma Proteomics. PROTEOMICS (2024)

Shawn J. RiceChandra P. Belani

low-cost precipitation methodsproteomicsenvironmental scienceplasma proteomics

Design of Experiments Approach for Systematic Optimization of a Single‐Shot Diapasef Plasma Proteomics Workflow Applicable for High‐Throughput. PROTEOMICS - CLINICAL APPLICATIONS (2023)

Shawn J. RiceChandra P. Belani

proteomicssystematic optimizationbiomedical engineeringclinical proteomics

Madhusmita BeheraRenjian JiangZhonglu HuangBecky BunnMurry W WynesJeffrey SwitchenkoGiorgio V ScagliottiChandra P BelaniSuresh S Ramalingam

pharmacodynamic studymedicinetriple-negative breast cancerpharmacologycancer carecancer researchsingle-agent veliparibpharmacotherapyanti-cancer agentsbreast canceroncologycancer treatment

Sarina Piha-PaulGeorge SimonChandra P BelaniHeman ChaoKim GasparBrenda LeeAfshin Dowlati

John Michael VarlottoZhuoxin SunBonnie KyJenica UpshawThomas J FitzgeraldMax DiehnChristine LovlyChandra BelaniKurt OettelGregory MastersMatthew HarkenriderHelen RossSuresh RamalingamNathan A Pennell

Molecular Testing and Patterns of Treatment in Patients With Nsclc: An Iaslc Analysis of Asco Cancerlinq Discovery Data.. Journal of Clinical Oncology (2022)

Optimizing Data‐Independent Acquisition (Dia) Spectral Library Workflows for Plasma Proteomics Studies. PROTEOMICS (2022)

Shawn J. RiceChandra P. Belani

proteomicsdata-independent acquisitiondata scienceplasma proteomics studiesspectral library workflows

1
2
3
4
5
31
10 / page

Similar Faculty Members

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Anthony Shields

Institution

Wayne State University

radiation oncology

gastrointestinal medical oncology

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Elisabeth Heath

Institution

Wayne State University

translational research

prostate cancer research

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Jeffrey Crawford

Institution

Duke University

mesothelioma

cancer care

Richard Schilsky

Institution

University of Chicago

cancer letter

cancer pharmacogenomics

Hedy Kindler

Institution

University of Chicago

mesothelioma

pathology

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research

Similar Faculty Members

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Anthony Shields

Institution

Wayne State University

radiation oncology

gastrointestinal medical oncology

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Elisabeth Heath

Institution

Wayne State University

translational research

prostate cancer research

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Jeffrey Crawford

Institution

Duke University

mesothelioma

cancer care

Richard Schilsky

Institution

University of Chicago

cancer letter

cancer pharmacogenomics

Hedy Kindler

Institution

University of Chicago

mesothelioma

pathology

Scott Joseph Antonia

Institution

Duke University

oncology

cancer research